FDA Adverse Event Injury Summary report: N

ADAPTER SLEEVE 11/13 +9

MDR report key: 2213385 · Received August 12, 2011

Report

Report Number
1818910-2011-14569
Event Type
Injury
Date Received
August 12, 2011
Date of Event
July 14, 2011
Report Date
October 28, 2013
Manufacturer
DEPUY-CORK, A DIV. OF DEPUY ORTHOPAEDICS
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

(B)(4). THERE IS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION. THE COMPLAINT IS CONSIDERED CLOSED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

PT WAS REVISED TO ADDRESS HIP PAIN WITH FEMORAL AND ACETABULAR LOOSENING AND OSTEOLYSIS.

Description of Event or Problem · 1

**UPDATE** (B)(4) 2013 - PLAINTIFF¿S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED DOB INFORMATION. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. THERE WAS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION. THE COMPLAINT WAS UPDATED ON (B)(4)2013.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADAPTER SLEEVE 11/13 +9 TOTAL HIP REPLACEMENT KWA DEPUY-CORK, A DIV. OF DEPUY ORTHOPAEDICS NA 2113854

Patients

Seq Age Sex Outcome Treatment
1 51 YR Required Intervention